Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 12 de 12
1.
Int J Antimicrob Agents ; 62(2): 106885, 2023 Aug.
Article En | MEDLINE | ID: mdl-37302771

OBJECTIVES: Oral combination of clindamycin and rifampicin is relevant for the treatment of staphylococcal osteoarticular infection (SOAIs). However, rifampicin induces CYP3A4, suggesting a pharmacokinetic interaction with clindamycin with unknown pharmacokinetic/pharmacodynamic (PK/PD) consequences. This study aimed to quantify clindamycin PK/PD markers before and during rifampicin co-administration in SOAI. METHODS: Patients with SOAI were included. After initial intravenous antistaphylococcal treatment, oral therapy was started with clindamycin (600 or 750 mg t.i.d.), followed by addition of rifampicin 36 h later. Population PK analysis was performed using the SAEM algorithm. PK/PD markers were compared with and without rifampicin co-administration, each patient being his own control. RESULTS: In 19 patients, clindamycin median (range) trough concentrations were 2.7 (0.3-8.9) mg/L and <0.05 (<0.05-0.3) mg/L before and during rifampicin administration, respectively. Rifampicin co-administration increased clindamycin clearance by a factor 16 and reduced the AUC0-8h/MIC by a factor 15 (P < 0.005). Clindamycin plasma concentrations were simulated for 1000 individuals, without and with rifampicin. Against a susceptible Staphylococcus aureus strain (clindamycin MIC 0.0625 mg/L), >80% of individuals would reach all proposed PK/PD targets without co-administration of rifampicin, even with low clindamycin dose. For the same strain, when rifampicin was co-administered, the probability to reach clindamycin PK/PD targets dropped to 1% for %fT>MIC = 100% and to 6% for AUC0-24h/MIC > 60, even with high clindamycin dose. CONCLUSION: Rifampicin co-administration with clindamycin has a high impact on clindamycin exposure and PK/PD targets in SOAI, which could result in clinical failure even for fully susceptible strains.


Rifampin , Staphylococcal Infections , Humans , Rifampin/therapeutic use , Clindamycin/therapeutic use , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Staphylococcal Infections/drug therapy , Staphylococcus aureus , Microbial Sensitivity Tests
2.
Rev Med Interne ; 43(6): 342-346, 2022 Jun.
Article Fr | MEDLINE | ID: mdl-35643787

INTRODUCTION: The rate of vaccination in HCWs in France remains low. We aimed to analyze the attitude and beliefs of HCWs toward influenza vaccination in Internal Medicine wards. METHODS: We conducted a cross-sectional survey of HCWs in the departments of Internal Medicine of two tertiary hospitals in France. An anonymous questionnaire designed for this study was used to collect demographic, health beliefs and attitudes, and medical knowledge related to the influenza and influenza vaccine. The survey started shortly prior the 2019 influenza season. RESULTS: The surveys were completed by 158 (29[18-62] years-old ; 75.9% female ; 69.6% non-medical workers) of 187 (84.5%) HCWs. Overall, influenza vaccination coverage rate was 50.6% (n=80/158). Higher vaccination coverage was found in physician and in HCWs who had a better knowledge about the virus transmission. The reason to fulfill vaccination recommendations was to protect the patients, their relatives and themselves for more than 80% of HCWs compliant to vaccination recommendation. More than a third of HCWs (n=59/158; 37.3%) refused to be vaccinated or hesitated. Among them, 12 (12/59, 20.3%) believed that influenza vaccine could cause flu. The main reasons for reluctant HCWs to eventually accept to be vaccinated were a mandatory vaccination program and the demonstration of a better vaccine efficacy to prevent the disease. CONCLUSION: Influenza vaccination coverage among HCWs in Internal Medicine remains low. Education campaigns targeting in priority nurses and nurse assistants is mandatory to improve the compliance of HCWs to vaccination recommendation.


Influenza Vaccines , Influenza, Human , Adolescent , Adult , Attitude of Health Personnel , Cross-Sectional Studies , Female , Health Personnel , Humans , Influenza Vaccines/therapeutic use , Influenza, Human/prevention & control , Male , Middle Aged , Surveys and Questionnaires , Vaccination , Young Adult
3.
Rev Med Interne ; 41(11): 727-731, 2020 Nov.
Article Fr | MEDLINE | ID: mdl-32753244

INTRODUCTION: A unique structure devoted to post-acute and rehabilitation care for patients under 75 with multiple comorbidities has been created within the Department of Internal Medicine, Bichat Hospital, Paris. We aim to report on demographic factors, clinical characteristics and outcomes of patients hospitalized in this pilot structure. METHODS: All consecutive adult patients admitted between May 2017 and May 2018 were retrospectively reviewed. RESULTS: Analysis was performed on 61 (61 [24-75] years-old) admitted patients. The median length of hospital stays was 108 [13-974] days. At admission, the median Charlson comorbidity index was 6 [0-12] predicting a 10-year survival of 21 [0-99]%. Most patients were unemployed (83.6%) and had very low-income (< national minimum wage in 65.6% of cases). At hospital discharge, most patients (85.4%) were able to return home. The complete resolution of health problems occurred in most cases (65.6%) and was associated with a lower probability of both hospital readmission and death 1-year after discharge. CONCLUSION: The structure served a high percentage of patients with major and complex health needs but limited access to care due to individual disabilities, low-income and underinsured status. However, despite major health disorders, functional limitations, and vulnerability, admission improved patient outcomes and reduced excess hospital readmissions in most cases.


Aftercare , Hospitals, Rehabilitation , Rehabilitation , Subacute Care , Adult , Aftercare/methods , Aftercare/organization & administration , Aftercare/statistics & numerical data , Age Factors , Aged , Comorbidity , Female , Hospitals, Rehabilitation/organization & administration , Hospitals, Rehabilitation/standards , Hospitals, Rehabilitation/statistics & numerical data , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Paris/epidemiology , Patient Readmission/statistics & numerical data , Pilot Projects , Rehabilitation/methods , Rehabilitation/organization & administration , Rehabilitation/statistics & numerical data , Retrospective Studies , Subacute Care/methods , Subacute Care/organization & administration , Subacute Care/statistics & numerical data , Young Adult
4.
Rev Med Interne ; 39(6): 386-392, 2018 Jun.
Article Fr | MEDLINE | ID: mdl-29571580

INTRODUCTION: Vaccination against influenza virus and Streptococcus pneumoniae is a global health priority and authorities, on the basis of recent publications, have recently updated French recommendations. The aim of this study was to describe the influenzae and pneumococcal vaccination's rate in an internal medicine ward. MATERIAL AND METHODS: All patients consecutively hospitalized during a 10 week-period in an internal medicine ward were included. The reasons for non-vaccination and the impact of an educational program for corrective measures were reported. RESULTS: Overall, 198 consecutive patients were included; 93 (47%) were immunocompromised; 142 (71.2%) had an indication for pneumococcal vaccination and 171 (86.4%) for influenza vaccination but only 16.2% and 55% of them were vaccinated against these microorganisms, respectively. Prior pneumococcal vaccination was more frequently observed in immunocompromised patients than in non-immunocompromised patients (21.1 versus 6.4%; P=0.029), but no significant difference was observed for influenza vaccine. Corrective measures were initiated in 46 patients (39%), non-immunized against S. pneumoniae. CONCLUSION: These results underline the very low prevalence of pneumococcal vaccination rate in at-risk hospitalized patients, as compared with influenza, despite recent recommendations.


Influenza, Human/prevention & control , Internal Medicine , Patient Admission/statistics & numerical data , Pneumonia, Pneumococcal/prevention & control , Vaccination/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , France/epidemiology , Hospital Units/statistics & numerical data , Humans , Immunocompromised Host , Influenza Vaccines/therapeutic use , Influenza, Human/epidemiology , Internal Medicine/statistics & numerical data , Male , Middle Aged , Pneumococcal Vaccines/therapeutic use , Pneumonia, Pneumococcal/epidemiology , Prevalence , Streptococcus pneumoniae/immunology , Young Adult
6.
Med Mal Infect ; 47(3): 206-220, 2017 May.
Article En | MEDLINE | ID: mdl-28336304

Infectious encephalitis is a severe disease leading to a high mortality and morbidity. The most frequent causes include Herpes simplex virus, Varicella Zoster virus, Listeria monocytogenes, and Mycobacterium tuberculosis. Urgent treatment is required (anti-infective therapy and nonspecific supportive care). The aim of this study was to define treatment strategy, empirical and after microbiological documentation at 48hours, through a systematic literature review.


Infectious Encephalitis/therapy , Adult , Anti-Infective Agents/therapeutic use , Anticonvulsants/therapeutic use , Brain Damage, Chronic/prevention & control , Critical Care , Diagnosis, Differential , Disease Management , France/epidemiology , Hospitalization , Humans , Hypertonic Solutions/therapeutic use , Hypothermia, Induced , Infectious Encephalitis/complications , Infectious Encephalitis/epidemiology
7.
Rev Med Interne ; 36(12): 854-8, 2015 Dec.
Article Fr | MEDLINE | ID: mdl-25912080

INTRODUCTION: Bovine ketosis is a rare cause of metabolic acidosis. It is a starvation ketosis that appears in lactating woman. CASE REPORT: A 29-year-old woman had a previous gastric surgery one month ago while breastfeeding her 6-month child. She presented to emergency with dyspnea, fatigue, weight loss and anorexia. The explorations revealed a serious metabolic acidosis with a high anion gap, for which all other causes have been eliminated. CONCLUSION: A restrictive diet in lactating patients is a major risk of ketosis or bovine ketosis. Medico-surgical treatment of obesity during lactation seems unreasonable. Breastfeeding should be systematically sought before a medical and surgical management of obesity. With the spread of bariatric surgery, starvation ketosis is a cause of metabolic acidosis not to ignore.


Breast Feeding , Ketosis , Lactation/metabolism , Postoperative Complications , Adult , Bariatric Surgery , Fasting , Female , Humans , Ketosis/diagnosis , Ketosis/etiology , Postoperative Complications/diagnosis , Postoperative Complications/etiology
8.
Rev Med Interne ; 35(10): 676-9, 2014 Oct.
Article Fr | MEDLINE | ID: mdl-24290029

INTRODUCTION: Adulterants are compounds added to street drugs to increase profits for the seller. Levamisole, a veterinary antihelminthic agent, has become the most common adulterant of cocaine. The prevalence of levamisole in samples of cocaine is increasing. Levamisole can lead to neutropenia and to a dramatic vasculopathy and even vasculitis of small and medium-size blood vessels. CASE REPORT: We here reported the first French case of levamisole related toxicity, due to cocaine use in a 50-year-old man, revealed by fever and agranulocytosis, high titters of antineutrophil cytoplasmic antibodies (ANCA), anticoagulant and positive Coombs tests. Outcome was slowly favorable with exposition withdrawal. CONCLUSION: Clinicians should be aware that agranulocytosis or vasculitis or vasculopathy could be related to levamisole toxicity in individuals who use cocaine.


Agranulocytosis/chemically induced , Cocaine-Related Disorders/complications , Drug Contamination , Drug Users , Levamisole/poisoning , Vasculitis/chemically induced , Agranulocytosis/complications , Agranulocytosis/diagnosis , Humans , Male , Middle Aged , Vasculitis/complications , Vasculitis/diagnosis
9.
J Hosp Infect ; 84(4): 294-9, 2013 Aug.
Article En | MEDLINE | ID: mdl-23846237

BACKGROUND: Extended-spectrum ß-lactamase-producing Escherichia coli (ESBLEC) is an increasing cause of hospital-acquired infection. Risk factors for ESBLEC colonization and infection have been reported, but information is lacking about the risk factors for acquiring ESBLEC infection in patients with prior colonization. AIM: To identify risk factors for development of infection in patients colonized with ESBLEC. METHODS: A retrospective study was performed at Hôpital Necker-Enfants Malades, Paris from 2007 to 2010. A multi-variable model was created to compare a group of patients with nosocomial ESBLEC infection following documented ESBLEC colonization with a control group of patients colonized with ESBLEC (case-control design). FINDINGS: In total, 118 patients were included: 40 (26 adults, 14 children) with colonization and infection and 78 (51 adults, 27 children) with colonization alone. The median time from colonization to infection was 12.5 days [25-75% confidence interval (CI) 5-40]. ESBLEC infections included urinary tract infection (85%), bacteraemia (7.5%) and lower respiratory tract infection (7.5%). On multi-variate analysis, use of ß-lactam/ß-lactamase inhibitor prior to infection [odds ratio (OR) 3.2, 95% CI 1.073-9.864); P = 0.037] and urinary catheterization were reported as risk factors for ESBLEC infection in colonized patients (OR 5.2, 95% CI 1.984-13.569; P = 0.0008). CONCLUSION: Identification of these risk factors will be helpful to identify patients colonized with ESBLEC who will require antibiotics for ESBLEC in the case of nosocomial infection. Limiting the use of specific antibiotics and controlling the duration of urinary catheterization will be helpful for prevention of ESBLEC infection.


Cross Infection/microbiology , Escherichia coli Infections/microbiology , Escherichia coli/enzymology , beta-Lactamases/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Case-Control Studies , Catheterization , Child , Child, Preschool , Cross Infection/epidemiology , Cross Infection/prevention & control , Drug Utilization , Escherichia coli/isolation & purification , Escherichia coli Infections/epidemiology , Escherichia coli Infections/prevention & control , Female , Humans , Infant , Male , Middle Aged , Paris/epidemiology , Retrospective Studies , Risk Factors , Young Adult
10.
Cerebrovasc Dis ; 35(4): 327-36, 2013.
Article En | MEDLINE | ID: mdl-23615478

BACKGROUND: Cerebral complications are well-identified causes of morbidity and mortality in patients with infective endocarditis (IE). Few studies have analysed the impact of brain magnetic resonance imaging (MRI) in IE patients with neurological manifestations. OBJECTIVES: The aims of this study were to assess the MRI contribution to the management of patients with IE neurological manifestations and to compare cerebral CT and MRI findings. MATERIAL AND METHODS: Patients with definite or probable IE and neurological manifestations were prospectively enrolled from 2005 to 2008, in a university hospital (Bichat Claude Bernard Hospital, Paris). Clinical and radiological characteristics and echocardiographic findings were systematically recorded. Brain MRI with angiography was performed and compared to available CT scans. The contribution of MRI results to cerebral involvement staging and to therapeutic plans was evaluated. RESULTS: Thirty patients, 37-89 years old, were included. Nineteen suffered from pre-existing heart disease. Blood cultures were positive in 29 cases and the main micro-organisms were streptococci (n = 14) and staphylococci (n = 13). The IE was mainly located on mitral (n = 15) and aortic valves (n = 13). Neurological events were strokes (n = 12), meningitis (n = 5), seizures (n = 1), impaired consciousness (n = 11) and severe headache (n = 1). MRI findings included ischaemic lesions (n = 25), haemorrhagic lesions (n = 2), subarachnoid haemorrhage (n = 5), brain abscess (n = 6), mycotic aneurysm (n = 7), vascular occlusion (n = 3) and cerebral microbleeds (n = 17). In 19/30 cases, neurological manifestations were observed before the diagnosis of IE. MRI was more sensitive than CT scan in detecting both clinically symptomatic cerebral lesions (100 and 81%, respectively) and additional asymptomatic lesions (50 and 23%, respectively). Therapeutic plans were modified according to MRI results in 27% of patients: antibiotherapy regimen modifications in 7% (switch for molecules with high cerebral diffusion) and surgical plan modifications in 20% (indication of valvular replacement due to the embolic nature of the vegetations revealed by MRI or postponement of surgery due to haemorrhagic lesions). None of the 16/30 (51%) operated-on patients experienced postoperative neurological worsening. In-hospital death occurred in 4 patients. CONCLUSION: In patients with IE neurological manifestations, MRI revealed a broader involvement of the brain (type and number of lesions) than indicated by clinical signs and/or CT scan. With a better disease staging of neurological manifestations, MRI brain imaging may help in patient management and the decision-making process especially for cardiac surgery indication and timing of valve replacement.


Brain Diseases/diagnosis , Brain/blood supply , Brain/pathology , Cerebral Angiography/methods , Cerebral Arteries/pathology , Diffusion Magnetic Resonance Imaging , Endocarditis, Bacterial/complications , Magnetic Resonance Angiography , Adult , Aged , Aged, 80 and over , Brain/diagnostic imaging , Brain Diseases/etiology , Brain Diseases/mortality , Brain Diseases/pathology , Brain Diseases/therapy , Cerebral Arteries/diagnostic imaging , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/etiology , Echocardiography , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/microbiology , Endocarditis, Bacterial/mortality , Endocarditis, Bacterial/therapy , Female , Hospitals, University , Humans , Male , Middle Aged , Paris , Predictive Value of Tests , Prognosis , Prospective Studies , Tomography, X-Ray Computed
11.
Recent Pat Antiinfect Drug Discov ; 6(1): 45-53, 2011 Jan.
Article En | MEDLINE | ID: mdl-21192777

Although carbapenem antibiotics are one of the most effective agents in the treatment of nosocomial infections caused by Gram-negative bacteria, their use is threatened by the emergence of antibiotic resistance. The bacterial resistance to carbapenems parallels their increasing use and has dramatic clinical implications such as increase in mortality and cost of care. This article reviews recently published patents claiming for carbapenem antibacterial agents. New forms including crystalline forms with high oral bioavailability and modified spectrum including methicillin-resistant Staphylococci are some of new patents described in this review.


Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Cross Infection/drug therapy , Gram-Negative Bacterial Infections/drug therapy , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/therapeutic use , Carbapenems/chemistry , Carbapenems/therapeutic use , Cross Infection/microbiology , Dosage Forms , Drug Resistance, Microbial , Humans , Patents as Topic
...